Finally, six key risk genes with CBR1, CCDC102A, LGALS1, SLC29A2, RD3L and TWIST1 were examined for expression levels using qPCR in 10 AML patients and 10 healthy donors. This evidence concerns the gene CBR1 and acute myeloid leukemia.